Our research is at the interface of molecular/cellular engineering, nanotechnology, and cancer research. We focus on the rational design and engineering of novel nanoscale and molecular therapeutics for ablation of the advanced cancer cell phenotype. Current research thrusts include:

• Biodegradable nanovectors for cancer therapy and imaging (funded by NCI / NIH)

• Intracellular trafficking of nanoparticles in cancer cells

• Microfluidic BioMEMS devices for the identification of novel combination treatments for cancer (funded by Wendy Will Case Cancer Fund)

• Host-tumor interactions

• Polymers for cancer gene therapy